Navigation Links
Bionovo's Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™
Date:3/28/2012

EMERYVILLE, Calif., March 28, 2012 /PRNewswire/ -- Bionovo, Inc. (OTCQB: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced today that the Company's independent Data Safety Monitoring Board (DSMB) recommended that the Phase 3 trial of Menerba (MF101) could continue as designed after an initial review of its clinical safety and tolerability data. Menerba is Bionovo's oral botanical drug candidate designed for the safe and effective treatment of vasomotor symptoms (hot flashes) associated with menopause.

The DSMB evaluated unblinded safety and dose tolerability data after 66 participants were randomized and on study medication for at least 30 days.  After an independent review of the data, the DSMB issued their positive recommendation to continue the trial as originally designed and no concerning safety signals were identified.

"I am very encouraged by the positive recommendation from our independent DSMB. This assurance that Menerba™ continues to be a safe, well-tolerated, non-estrogen alternative therapy for the treatment of menopausal hot flashes is consistent with the promising results of our early clinical trial data and extensive pre-clinical toxicity studies. We are very eager to continue to develop a safe and effective treatment for post-menopausal hot flashes, a drug that can be the leading seller in the well established multibillion dollar market," said Mary Tagliaferri, M.D., Bionovo's President and Chief Medical Officer.  

The MF101-004 Phase 3 pivotal study dosed its first patient on November 16, 2011. To date, a total of 280 postmenopausal women have been randomized to the trial. Recruitment to the Phase 3 trial was voluntarily halted on March 9, 2012 as Bionovo does not have adequate funding to further advance the registration trial. Bionovo will need to secure additional financing to complete either a
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Halo Therapeutics Reports Favorable Independent Review of Lead Drug Candidate HT-100
2. New Survey: Walgreens Customers Flock to Independent Pharmacies
3. EPS Security to Add "Medical Alert" Services for Independent Seniors
4. Independent Data Published on BioLife Solutions HypoThermosol® and CryoStor®
5. Aria Announces Publication of Independent Study in the American Journal of Obstetrics & Gynecology Using Arias Technology
6. Parata Systems Announces Presenting Sponsorship of 2012 Independent Pharmacy Business Growth Conference
7. Winner Medical Appoints BDO China as Independent Auditor
8. NCPA Launches Initiative to Help Independent Community Pharmacies Create Better Business Opportunities for Front-End Merchandise
9. Independent Laboratory Testing Demonstrates Important Quality Differences Between FDA-Approved Makena® and Compounded 17P Formulations
10. Adeona Appoints Jeff Lucero Riley as Independent Chairman
11. NCPA Digest Finds Independent Community Pharmacies Reducing Health Costs Through Generic Drug Use, Patient Counseling
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 Research and ... of the  "North America Mammography Market - ...  report to their offering. ... a detailed type of imaging that customs ... A mammography exam, called a mammogram, is ...
(Date:5/27/2015)... , May 27, 2015 OpportunityAnalyzer: Cushing,s ... Summary GlobalData estimates that the 2013 ... was approximately $179m across the 6MM covered in ... investing their attention, time, and financial resources in ... research and development (R&D) strategies. One notable example ...
(Date:5/27/2015)... May 27, 2015 ... has announced the addition of the  "2015 ... Market"  report to their offering. ... issues pertaining to the US NAT laboratory ... demographic, social and technological trends with significant ...
Breaking Medicine Technology:North America Mammography Market - Growth, Trends And Forecasts (2014 - 2019) 2OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 2OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 3OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 4United States Nucleic Acid Testing Market Strategies 2015-2020 2
... WOONSOCKET, R.I., May 23, 2012  New research sponsored ... and Drug Administration (FDA) drug warnings on medication ... clear clinical recommendations. The research found that immediately ... for a cholesterol-lowering drug, the monthly level of ...
... -- China Botanic Pharmaceutical Inc. (NYSE AMEX: ... a developer, manufacturer and distributor of botanical products, ... today announced that the Company recently attended the ... Fair") held in Guangzhou, China. China ...
Cached Medicine Technology:CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety 2CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety 3China Botanic Attends the 111th China Import and Export Fair 2China Botanic Attends the 111th China Import and Export Fair 3
(Date:5/27/2015)... San Marcos, CA (PRWEB) May 27, 2015 ... a solution to help patients - who need extensive dental ... as well as treatment options customized for their problems. , ... consists in a visual presentation of the assessment of the ... most suitable options, which can treat their oral health problems. ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 In support ... April 2015 issue of the Journal of American Geriatrics ... and abdominal obesity, Bedford Commons OB-GYN P.A . ... of non-nutritive sweetener-flavored beverages. , To examine the ... a comprehensive San Antonio Longitudinal Study of Aging (SALSA) ...
(Date:5/27/2015)... NY (PRWEB) May 27, 2015 Difass ... launched in the U.S. with its first three flagship ... available for purchase nationwide through http://www.difassusa.com . ... person’s health and productivity, but some people struggle with ... night. Dormiva™ is a sleep aid designed to help ...
(Date:5/27/2015)... This is a professional and in-depth ... industry. The report provides a basic overview of ... chain structure. The Omega-3 market analysis is provided ... landscape analysis, and key regions development status. Lysi, ... Seadragon Marine Oils, Norwegian Fish Oil, Croda Health ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 With a ... a poll conducted during the "ACA - Controlling the ... participants, 75% are currently in the process of researching ... 15% were confidently prepared for the reporting mandates. , ... during the webinar, those who are currently vetting ACA ...
Breaking Medicine News(10 mins):Health News:San Marcos Dentistry Office Offering a New Service Dental Case Planning 2Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2Health News:Omega-3 Market: Global 2015 Analysis & 2020 Forecasts on Market Size 2Health News:Employers are On Track for ACA Reporting According to Businessolver Poll 2
... Arena Pharmaceuticals, Inc.,(Nasdaq: ARNA ) announced today the ... common stock at a public offering price of $9.91,per ... Arena. The underwriters,have a 30-day option to purchase up ... over-allotments, if any. CIBC World Markets and UBS ...
... Perrigo Company,(Nasdaq: PRGO ; TASE) announced ... for store brand OTC 20mg Omeprazole delayed,release tablet, ... of Prilosec OTC(R)) involving three Orange Book patents ... terms and conditions of the,agreement have not been ...
... HHS Secretary Mike,Leavitt signed a Memorandum of ... today to improve the health status of indigenous,communities ... practices, and innovative approaches to learning,opportunities., The ... national,headquarters., The MOU, which continues the work ...
... Wagoner on the $28 million increase in,abstinence-only ... The following is a,statement by James Wagoner ... funding:, Today, we learned that the ... the full $28 million,increase requested by President ...
... Ill., Nov. 1 Z Trim Holdings, Inc.,(Amex: ... Current Report on Form 8-K,with the Securities Exchange Commission ... a result of a determination by Z,Trim that those ... Company determined that its financial statements for the,quarters ended ...
... Nov. 1 Masimo, the inventor,of Pulse CO-Oximetry ... the completion of CHN,s system-wide implementation of,Masimo SET ... superior,Masimo SET performance in other areas of its ... oximetry technology to virtually every site --,making Masimo ...
Cached Medicine News:Health News:Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Health News:Perrigo Announces that Dexcel's Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval 2Health News:Perrigo Announces that Dexcel's Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval 3Health News:HHS Secretary Leavitt Signs Agreement With Canada to Improve Indigenous Health Care Delivery and Access 2Health News:Democrats Cave on Sex Education - Again 2Health News:Z Trim Holdings Reports Restatement of Previously Issued Financial Statements; Amends Bylaws 2Health News:Z Trim Holdings Reports Restatement of Previously Issued Financial Statements; Amends Bylaws 3Health News:Z Trim Holdings Reports Restatement of Previously Issued Financial Statements; Amends Bylaws 4Health News:Z Trim Holdings Reports Restatement of Previously Issued Financial Statements; Amends Bylaws 5Health News:Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 2Health News:Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 3Health News:Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 4
... The Topcon OV-200 Ophthalmic Viewer, ... footprint, makes photographic interpretation more precise, ... From fundus transparencies, anterior segment or ... angiography, the OV-200 fulfills all your ...
... This sleek, contoured instrument table ... room dcor, while providing a sturdy, ... wheelchair compatible design provides completely open ... make positioning quick and easy. The ...
The new ACP-8R Automatic Chart Projector features 30 random access charts with multiple 20/20 and 20/15 lines, which are ideal for LASIK centers and for post-surgical determination of precise visual ...
... FDA-Approved BV-1000 is the worlds ... system. With the BV-1000, Topcon ... of refracting instruments. This innovative ... binocular auto-refractor, auto-keratometer, automatic chart ...
Medicine Products: